ASCLS eNewsBytes

• Having MS and depression significantly raises mortality risk September 13, 2021
  Nearly 1 million people in the United States have MS, a central nervous system disease with a variable and sometimes disabling course. Women are three times more likely to develop MS than men, and people typically receive a diagnosis between 20-50 years of age.
• UK researchers report 'reassuring' data on long-term MIS-C outcomes September 13, 2021
  Researchers in the United Kingdom reported “reassuring” data on the one-year outcomes of dozens of children who had a serious inflammatory syndrome triggered by SARS-CoV-2 infection. The illness now known as multisystem inflammatory syndrome in children was first characterized by physicians in London in April 2020. According to the CDC, 4,404 children in the United […]
• Study offers reassuring findings on HIV-to-HIV transplants September 13, 2021
  HIV-to-HIV transplantation is on the rise, and there are many donors with good organ quality and an acceptable risk profile in terms of post-transplant ART for prevention of HIV superinfection, according to a recent study. “There is an ongoing organ shortage in the United States, and end organ disease is common in people with HIV,” […]
• Speech study using AI technology to spot ALS biomarkers September 13, 2021
  A technology based on artificial intelligence is helping to spot biomarkers and document the progression of amyotrophic lateral sclerosis in a large speech study being conducted by EverythingALS.
• Chagas disease: New study to confirm the effectiveness of a shorter treatment September 13, 2021
  A clinical trial has been launched in Argentina to see if a shorter regimen of the drug benznidazole has the potential to become a new standard treatment for Chagas disease to treat adult patients in the chronic phase of the disease, with fewer side effects.